Development of novel targeted therapies in the treatment of malignant glioma
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (5), 430-446
- https://doi.org/10.1038/nrd1380
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- The Hallmarks of CancerCell, 2000
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Cancer Cell CyclesScience, 1996
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994